Related Experiment Video
Updated: Jul 6, 2026
10:52
Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Severe tricuspid stenosis during percutaneous occlusion of perimembranous ventricular septal defect with the new
Luiz A Christiani1, Fábio Bergman, João C Tress
1Hospital Universitário Pedro Ernesto, Rio de Janeiro, Brazil. lzchris@terra.com.br
Congenital Heart Disease
|April 2, 2008
Abstract
Background:
The new Amplatzer device has been used with success for occlusion of the perimembranous ventricular septal defects and the index of complications is very low.
Results:
The reported case corresponds to a very rare severe acute tricuspid stenosis, caused by adherence of the prosthesis to the anterior tricuspid leaflet.
Conclusion:
Device release was achieved by manipulation on the tricuspid apparatus.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...